Filtros de búsqueda

Lista de obras de Valeria Piazzolla

8 FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND WEIGHT BASED RIBAVIRIN COMBINATION

A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus

artículo científico publicado en 2020

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response

artículo científico publicado en 2010

IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients

artículo científico publicado en 2011

Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience

artículo científico publicado en 2014

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.

artículo científico publicado en 2010

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR ⬇️

artículo científico publicado el 10 de enero de 2011

Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study

article

Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

artículo científico publicado en 2011

Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution

artículo científico publicado en 2013

Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus

artículo científico publicado en 2018

Overall efficacy and safety results of sofosbuvir-based therapies in phase II and III studies

artículo científico publicado en 2014

Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection

artículo científico publicado en 2014

Reply to: "Built-in bias in HCV clearance in acute HCV infection".

artículo científico publicado en 2013

Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin.

artículo científico publicado en 2010

Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.

artículo científico publicado en 2016

The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin

artículo científico publicado en 2016

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda